135 related articles for article (PubMed ID: 12043854)
1. Twice-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Mendelson L; Cook D; Cruz-Rivera M; Fitzpatrick S; Smith JA
J Asthma; 2002 May; 39(3):227-37. PubMed ID: 12043854
[TBL] [Abstract][Full Text] [Related]
2. Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Scott MB; Ellis MH; Cruz-Rivera M; Fitzpatrick S; Smith JA
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):488-95. PubMed ID: 11770696
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
White MV; Cruz-Rivera M; Walton-Bowen K
Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
Mellon M
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
[TBL] [Abstract][Full Text] [Related]
5. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma.
Mellon M; Leflein J; Walton-Bowen K; Cruz-Rivera M; Fitzpatrick S; Smith JA
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):593-8. PubMed ID: 10934092
[TBL] [Abstract][Full Text] [Related]
6. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
7. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.
Baker JW; Mellon M; Wald J; Welch M; Cruz-Rivera M; Walton-Bowen K
Pediatrics; 1999 Feb; 103(2):414-21. PubMed ID: 9925834
[TBL] [Abstract][Full Text] [Related]
8. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
Kemp JP; Skoner DP; Szefler SJ; Walton-Bowen K; Cruz-Rivera M; Smith JA
Ann Allergy Asthma Immunol; 1999 Sep; 83(3):231-9. PubMed ID: 10507269
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma.
Shapiro G; Mendelson L; Kraemer MJ; Cruz-Rivera M; Walton-Bowen K; Smith JA
J Allergy Clin Immunol; 1998 Nov; 102(5):789-96. PubMed ID: 9819296
[TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
Scott MB; Skoner DP
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
[TBL] [Abstract][Full Text] [Related]
11. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
12. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma.
Szefler SJ; Eigen H
J Allergy Clin Immunol; 2002 Apr; 109(4):730-42. PubMed ID: 11941331
[TBL] [Abstract][Full Text] [Related]
13. Effect of high starting dose of budesonide inhalation suspension on serum cortisol concentration in young children with recurrent wheezing episodes.
Volovitz B; Nussinovitch M
J Asthma; 2003 Sep; 40(6):625-9. PubMed ID: 14579993
[TBL] [Abstract][Full Text] [Related]
14. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
Leflein JG; Szefler SJ; Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Smith JA
Pediatrics; 2002 May; 109(5):866-72. PubMed ID: 11986448
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers.
Kerwin EM; Pearlman DS; de Guia T; Carlsson LG; Gillen M; Uryniak T; Simonson SG
Curr Med Res Opin; 2008 May; 24(5):1497-510. PubMed ID: 18419878
[TBL] [Abstract][Full Text] [Related]
16. Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze.
Berger WE; Qaqundah PY; Blake K; Rodriguez-Santana J; Irani AM; Xu J; Goldman M
J Pediatr; 2005 Jan; 146(1):91-5. PubMed ID: 15644830
[TBL] [Abstract][Full Text] [Related]
17. Asthma control in pediatric patients treated with once-daily or twice-daily nebulized budesonide inhalation suspension (Pulmicort Respules).
Baker JW; Kemp J; Uryniak T; Silkoff PE
Allergy Asthma Proc; 2008; 29(3):280-5. PubMed ID: 18534086
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nighttime sleep diary in asthmatic children.
Yoshihara S; Kanno N; Fukuda H; Yamada Y; Fukuda N; Tsuchiya T; Arisaka O
Pediatr Allergy Immunol; 2011 Nov; 22(7):667-70. PubMed ID: 21950678
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
20. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
Eid NS; Noonan MJ; Chipps B; Parasuraman B; Miller CJ; O'Brien CD
Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
